OpenEvidence 已完成 2.5 亿美元的额外融资，使其总估值达到 150 亿美元。该公司利用 AI 来增强临床决策支持工具。这轮最新的融资凸显了投资者对该公司技术和市场地位的极大信心。 AI
影响 这笔资金可能会加速 AI 驱动的临床决策支持工具的开发和部署，从而有可能改善医疗保健结果。
排序理由 一家专注于 AI 的公司的重大融资轮次。
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
OpenEvidence 以 150 亿美元估值完成 2.5 亿美元融资，用于 AI 临床工具
本文如何被排名
- Signal score
- 0 / 100
- Composite score across the factors below. Higher = stronger signal that this story matters right now.
- Newsworthiness bucket
- Research
- 一家专注于 AI 的公司的重大融资轮次。
- Source corroboration
- Single-source cluster
- Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
- Topics
- funding, product, infra
- Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
- AI-industry relevance
- High
- Clearly on-topic for AI-industry coverage.
- Story freshness
- 10 days old
- Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.
完整方法见我们的编辑标准。
报道来源 [1]
-
OpenEvidence 确认已以 150 亿美元估值完成 2.5 亿美元的追加融资
OpenEvidence is a leading AI driven clinical decision support tool.